Silvia Corvera

Silvia Corvera is a Professor of Molecular Medicine and holds the Endowed Chair in Diabetes Research at the University of Massachusetts Chan Medical School, within the T.H. Chan School of Medicine's Program in Molecular Medicine. She also serves as Director of the MD/PhD (MSTP) program and the Clinical Translational Research Pathway. Her academic journey includes an MD and MSc in Molecular Biology from the Universidad Nacional Autonoma de Mexico, followed by postdoctoral studies in the U.S. and faculty roles at the University of Pennsylvania and UMass Chan.

Her research focuses on understanding cellular and molecular mechanisms underlying metabolic diseases such as type-2 diabetes, non-alcoholic fatty liver disease (NASH), and hypertension. Key areas include adipose tissue dynamics—specifically adipocyte expansion, brite/beige adipocyte function, and adipose organoid development. Collaborations with clinical partners in surgery and obstetrics-gynecology enhance translational research into metabolic disease associations with adipose distribution patterns.

Dr. Corvera’s laboratory explores adipose tissue heterogeneity, including its role in energy homeostasis and therapeutic potential. Current projects involve analyzing adipose cell populations via single-cell RNAseq and investigating how genetic factors influence adipose patterning. Her work bridges basic science and clinical applications, addressing obesity-related pathologies and regenerative medicine opportunities.

Notable contributions include defining adipose tissue angiogenesis in obesity, generating functional human adipose tissue in vivo, and elucidating mechanisms of adipocyte progenitor differentiation. Her lab actively engages trainees in rotation projects focused on adipocyte biology, cell signaling, and metabolic pathways.

Lab activities emphasize interdisciplinary approaches, combining molecular biology, stem cell technology, and systems biology to advance treatments for metabolic disorders. Ongoing efforts investigate adipose-derived cell therapies, CRISPR-enhanced adipocyte browning, and the role of long noncoding RNAs in thermogenesis regulation.